Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Anna Scott joining Mercer
Markets

Anna Scott joining Mercer

Former Smart boss will replace current Mercer chief executive Martin Lewington.

Solar still on the rise, Ecotricity says
Markets

Solar still on the rise, Ecotricity says

Commercial solar generation is up almost 300%.

Expectations of rate cuts boost NZ sharemarket in light trade
Markets Market close

Expectations of rate cuts boost NZ sharemarket in light trade

There were 89 rises and 48 falls on the main board.

Jamie Gray 02 Jul 2025